0001123292-16-002943.txt : 20161103
0001123292-16-002943.hdr.sgml : 20161103
20161103161304
ACCESSION NUMBER: 0001123292-16-002943
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151123
FILED AS OF DATE: 20161103
DATE AS OF CHANGE: 20161103
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Recro Pharma, Inc.
CENTRAL INDEX KEY: 0001588972
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 261523233
STATE OF INCORPORATION: PA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 490 LAPP ROAD
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: (484) 395-2400
MAIL ADDRESS:
STREET 1: 490 LAPP ROAD
CITY: MALVERN
STATE: PA
ZIP: 19355
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Weisman Wayne
CENTRAL INDEX KEY: 0001602327
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36329
FILM NUMBER: 161971730
MAIL ADDRESS:
STREET 1: 490 LAPP ROAD
CITY: MALVERN
STATE: PA
ZIP: 19355
4/A
1
edgar.xml
PRIMARY DOCUMENT
X0306
4/A
2015-11-23
2016-05-23
0001588972
Recro Pharma, Inc.
REPH
0001602327
Weisman Wayne
490 LAPP ROAD
MALVERN
PA
19355
1
0
0
0
Common Stock
0
D
On May 23, 2016, the reporting person filed a Form 4 mistakenly reporting indirect beneficial ownership for shares of common stock owned by SCP Vitalife Partners (Israel) II, L.P. and SCP Vitalife Partners II L.P and sold in fourteen transactions occurring between November 23, 2015 through May 20, 2016, which consisted of the sale of an aggregate of 58,331 shares of common stock. During the period from November 23, 2015 through May 20, 2016, the reporting person did not have indirect beneficial ownership of such shares.
/s/ Donna Nichols, attorney-in-fact
2016-11-03